Greg Feero, MD, PhD, Director of Research

Medical School: University of Pittsburgh School of Medicine
Family Medicine Residency: Maine-Dartmouth Family Medicine Residency

Dr. Feero attended the University of Pittsburgh School of Medicine and graduated with an M.D., Ph.D. (Human Genetics) in 1998. He then completed his medical training at the Maine-Dartmouth Family Medicine Residency in Augusta, Maine.  After five years on the faculty of the Maine-Dartmouth Family Medicine Residency, he accepted a position at the National Human Genome Research Institute, National Institutes of Health, where he was a senior advisor to the director, and branch chief of the Genomic Healthcare Branch in the Office of Policy, Communication and Education, Office of the Director. In 2009 he returned to Maine.  Dr. Feero is currently  an associate editor for the Journal of the American Medical Association and serves as co-chair of the National Academies of Science, Engineering, and Medicine Roundtable on Genomics and Precision Health. He has authored several book chapters and over 50 peer-reviewed publications and is board certified in family medicine. He is a professor in the Department of Community and Family Medicine at the Geisel School of Medicine at Dartmouth and  clinical associate professor at the University of New England College of Osteopathic Medicine. He currently sees patients at Four Seasons Family Practice in Fairfield, ME.

Additional activities have included:

  • Research Director, Maine-Dartmouth Family Medicine Residency, 2009-present
  • Director, Maine-Dartmouth–Colby College Summer Internship Program, 2012-present
  • Member, MaineGeneral Health Institutional Review Board, 2017-present
  • Physician at large representative, MaineGeneral Health Board of Directors, 2020-present
  • Maine-Dartmouth Family Medicine Residency representative to the Maine Medical Association Legislative Committee, 2017-present
  • Co-investigator, Ethical, Legal, and Social Policy Implications of Workplace Genomic Testing, National Human Genome Research Institute, grant number 1R01HG010679-01A1, 2020-present
  • Guest editor, “Genomic Medicine” article series, New England Journal of Medicine, 2008-2012

Dr. Feero’s more recent publications include:

Ginsburg G, Penny M, Feero WG, Miller M, Addie S, Beachy SH. The National Academies’ Roundtable on Genomics and Precision Health: Where we have been and where we are heading. Am J Hum Genet. 2021;108(10):1817-1822.

Sanghavi K, Feero WG, Mathews DJH, Prince AER, Price LL, Liu ET, Brothers KB, Roberts JS, Lee C. Employees’ views and ethical, legal, and social implications assessment of voluntary workplace genomic testing. Front Genet. 2021;12:643304.

Feero WG. Bioinformatics, sequencing accuracy, and the credibility of clinical genomics. JAMA. 2020; 324(19):1945-1947.

Feero WG, Wicklund CA. Consumer genomic testing in 2020. JAMA. 2020;323(15):1445-1446.

Feero WG. Genetic factors should be considered when caring for colorectal cancer survivors. Am Fam Physician. 2018;98(8):474-475.

Williams JK, Feero WG, Veenstra DL, Starkweather A, Cashion AK. Considerations in initiating genomic screening programs in health care systems. Nurs Outlook. 2018;66(6):570-575.

Khoury MJ, Feero WG, Chambers DA, Brody LE, Aziz N, Green RC, et al. A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health. PLoS Med 2018;15(8): e1002631.

Feero WG. Genetic factors should be considered when caring for colorectal cancer survivors. Am Fam Physician. 2018;98(8):474-475.

Feero WG, Wicklund CA, Veenstra D.  Precision medicine, genome sequencing, and improved population health.  JAMA. 2018;319(19):1979-1980.

Feero WG. Is “precision medicine” ready to use in primary care practice?  Yes: It offers patients more individualized ways of managing their health.  American Family Physician. 2017;15(96):767-768.

Feero WG. Introducing “genomics and precision health.” JAMA. 2017;317(18):1842-1843.